Paratek Pharmaceuticals I...

NASDAQ: PRTK · Real-Time Price · USD
2.23
0.04 (1.83%)
At close: Sep 20, 2023, 10:00 PM

Paratek Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-14.55M -20.14M -7.16M -20.88M -17.62M -17.91M -32.25M -18.2M 9.72M -18.35M
Depreciation & Amortization
46K 47K 86K 129K 131K 144K 78K 88K 115K 110K
Stock-Based Compensation
2.23M 2.15M 1.99M 3.98M 3.88M 2.47M 4.86M 2.88M 5M 1.6M
Other Working Capital
800K 248K 12.4M 9.31M 2.93M -634K 22.72M 8.69M -72K -2.24M
Other Non-Cash Items
1.2M 1.03M 1.35M 1.33M 1.2M 1.52M 3.28M 324K 337K 335K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
9.31M 28.01M -16.38M 3.02M -2.1M -5.33M 4.23M 41.17M -48.38M -5.22M
Operating Cash Flow
-1.78M 11.09M -20.11M -12.42M -14.5M -19.11M -19.81M 26.26M -33.21M -21.52M
Capital Expenditures
n/a -32K -36K n/a n/a -36K 6K 6K -117K -262K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a -15.16M n/a n/a -15.16M -15.12M n/a n/a n/a
Sales Maturities Of Investments
n/a n/a 30M n/a n/a n/a n/a n/a n/a 20M
Other Investing Acitivies
n/a n/a 15.2M n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
n/a -32K 30M n/a n/a -15.2M -15.12M 6K -117K 19.74M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-565K -280K -2.73M 1K 4.72M 3.1M 4.29M 9.44M 5M -394K
Financial Cash Flow
-565K -280K -2.73M 1K 4.72M 3.1M 4.29M 9.44M 5M -394K
Net Cash Flow
-2.34M 10.78M 7.16M -12.42M -9.78M -31.21M -30.63M 35.7M -28.33M -2.17M
Free Cash Flow
-1.78M 11.06M -20.15M -12.42M -14.5M -19.15M -19.8M 26.27M -33.32M -21.78M